Fund Holdings — Artia Global Partners LP

Total Portfolio Value:
$353.59M
Total Bought:
$43.49M
Total Sold:
$65.18M
Net Transaction:
-$21.69M
Notable People:
Onusa Nmn Chantanapongwanij, Artia Global Partners Gp Llc
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Novo Nordisk A/SADR(NVO)691,743741,743+50,000$98.74M$88.32M24.98%-$10.42M
Eli Lilly and Company(LLY)92,59392,5930$83.83M$82.03M23.20%-$1.80M
Viking Therapeutics, Inc.(VKTX)452,979532,879+79,900$24.01M$33.74M9.54%+$9.72M
Intra-Cellular Therapies Inc216,519216,5190$14.83M$15.84M4.48%+$1.01M
AstraZeneca PLCADR(AZN)190,752190,7520$14.88M$14.86M4.20%-$15.3K
Soleno Therapeutics Inc94,424274,424+180,000$3.85M$13.86M3.92%+$10.00M
Alnylam Pharmaceuticals, Inc.(ALNY)35,00035,0000$8.51M$9.63M2.72%+$1.12M
Vertex Pharmaceuticals Incorporated(VRTX)18,90018,9000$8.86M$8.79M2.49%-$68.8K
Vaxcyte, Inc.(PCVX)76,25576,2550$5.76M$8.71M2.46%+$2.96M
argenx SEADR(ARGX)15,13815,1380$6.51M$8.21M2.32%+$1.70M
Axsome Therapeutics, Inc.(AXSM)87,84887,8480$7.07M$7.89M2.23%+$823.1K
Protagonist Therapeutics Inc124,440124,4400$4.31M$5.60M1.58%+$1.29M
Neurocrine Biosciences, Inc.(NBIX)45,00045,0000$6.20M$5.18M1.47%-$1.01M
Revolution Medicines, Inc.(RVMD)095,885+95,885$0$4.35M1.23%+$4.35M
Dyne Therapeutics, Inc.(DYN)119,488119,4880$4.22M$4.29M1.21%+$75.3K
Verona Pharma PlcADS130,790148,590+17,800$1.89M$4.27M1.21%+$2.38M
Merus N V50,17180,171+30,000$2.97M$4.01M1.13%+$1.04M
Insmed Incorporated(INSM)53,43652,939-497$3.58M$3.86M1.09%+$284.3K
Celldex Therapeutics, Inc.(CLDX)75,30075,3000$2.79M$2.56M0.72%-$227.4K
Crinetics Pharmaceuticals In85,76545,765-40,000$3.84M$2.34M0.66%-$1.50M
IDEAYA Biosciences, Inc.(IDYA)54,39262,992+8,600$1.91M$2.00M0.56%+$85.9K
Mereo BioPharma Group plcADS(MREO)421,359421,3590$1.52M$1.73M0.49%+$214.9K
Springworks Therapeutics Inc53,93053,9300$2.03M$1.73M0.49%-$303.6K
Nuvalent Inc015,437+15,437$0$1.58M0.45%+$1.58M
Xenon Pharmaceuticals Inc.(XENE)40,00040,0000$1.56M$1.57M0.45%+$15.2K
Centessa Pharmaceuticals PlcADS080,380+80,380$0$1.29M0.36%+$1.29M
EyePoint, Inc.(EYPT)101,500156,300+54,800$883.0K$1.25M0.35%+$365.8K
Charles River Laboratories International, Inc.(CRL)6,9056,305-600$1.43M$1.24M0.35%-$184.5K
Ionis Pharmaceuticals, Inc.(IONS)62,47930,479-32,000$2.98M$1.22M0.35%-$1.76M
Keros Therapeutics, Inc.(KROS)20,00020,0000$914.0K$1.16M0.33%+$247.4K
Kura Oncology, Inc.(KURA)57,17857,1780$1.18M$1.12M0.32%-$60.0K
Ascendis Pharma A/SADR(ASND)7,4407,4400$1.01M$1.11M0.31%+$96.2K
Annexon, Inc.(ANNX)147,485172,226+24,741$722.7K$1.02M0.29%+$296.9K
Corbus Pharmaceuticals Holdings, Inc.(CRBP)20,00047,400+27,400$905.0K$977.9K0.28%+$72.9K
Silence Therapeutics plcADS(SLN)52,47652,4760$997.0K$954.0K0.27%-$43.0K
Syndax Pharmaceuticals, Inc.(SNDX)48,26348,2630$990.8K$929.1K0.26%-$61.8K
Newamsterdam Pharma Company
ORDINARY SHARES
54,28554,2850$1.04M$901.1K0.25%-$141.7K
Alector Inc0193,317+193,317$0$900.9K0.25%+$900.9K
Disc Medicine, Inc.(IRON)13,44013,4400$605.7K$660.4K0.19%+$54.7K
Larimar Therapeutics, Inc.(LRMR)90,49090,4900$656.1K$592.7K0.17%-$63.3K
Acelyrin Inc093,114+93,114$0$459.1K0.13%+$459.1K
Madrigal Pharmaceuticals, Inc.(MDGL)1,5571,5570$436.2K$330.4K0.09%-$105.8K
Summit Therapeutics Inc.(SMMT)014,512+14,512$0$317.8K0.09%+$317.8K
Q32 Bio Inc.(QTTB)04,705+4,705$0$209.9K0.06%+$209.9K
Apogee Therapeutics Inc58,4000-58,400$2.30M$0—-$2.30M
Merck & Co., Inc.(MRK)442,5040-442,504$54.78M$0—-$54.78M
Ocular Therapeutix, Inc.(OCUL)500,0000-500,000$3.42M$0—-$3.42M
Pliant Therapeutics, Inc.(PLRX)50,0000-50,000$537.5K$0—-$537.5K
Sarepta Therapeutics, Inc.(SRPT)2,6000-2,600$410.8K$0—-$410.8K
Page 1 of 1
Artia Global Partners LP — 13F Holdings — Q3 2024 | TickerTrail